KRAS G12C MUTATION
Clinical trials for KRAS G12C MUTATION explained in plain language.
Never miss a new study
Get alerted when new KRAS G12C MUTATION trials appear
Sign up with your email to follow new studies for KRAS G12C MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Genetic testing guides brain cancer fight
Disease control TerminatedThis study tests whether using genetic testing to match patients with specific drugs can help control cancer that has spread to the brain. It is for adults with solid tumors (like lung or breast cancer) that have spread to the brain and have certain genetic changes. Patients rece…
Matched conditions: KRAS G12C MUTATION
Phase: PHASE2 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Scientists hunt hidden causes of lung cancer drug resistance
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to understand why lung cancers with specific genetic changes eventually stop responding to targeted drug treatments. Researchers will analyze tumor and blood samples from 40 patients whose cancer progressed while on these drugs. They will use advanced genetic test…
Matched conditions: KRAS G12C MUTATION
Sponsor: Chang Gung Memorial Hospital • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC